Sunday, August 17, 2003

SEATTLE-AREA INVENTORS GRANTED PATENT FOR PREVENTING COLDS, FLUS AND INFECTIONS OF THE HUMAN RESPIRATORY SYSTEM

SEATTLE-AREA INVENTORS GRANTED PATENT FOR PREVENTING COLDS, FLUS AND INFECTIONS OF THE HUMAN RESPIRATORY SYSTEM

Just in time for the cold and flu season, founders of Woodinville, Washington-based Inhalation, Inc., have been granted patent No. 6, 447,816 today by the U. S. Patent and Trademark Office that is entitled “Methods and Apparatus to Prevent Colds, Flus, and Infections of the Human Respiratory System.” Co-invented by W. Banning Vail, Ph. D., an MIT-educated physicist and holder of over 50 patents in a variety of industries, and his wife, Marilyn L. Vail, the invention combines the age-old and well-documented antibacterial, antiviral, and antifungal benefits of eucalyptus and/or tea tree oil with a convenient, portable personal inhaler that effectively transports the vapors to the sinuses and into the lungs.

(PRWEB) September 15, 2002

Press Release

For more information, contact:

Nika Herford

Public Relations

Inhalation, Inc.

Phone: (206) 601-3616

 (425) 398-2557

Fax:  (425) 482-2013

E-mail: NikaH@NoColds-NoFlus. com

SEATTLE-AREA INVENTORS GRANTED PATENT FOR PREVENTING COLDS, FLUS AND INFECTIONS OF THE HUMAN RESPIRATORY SYSTEM

Woodinville, Wash., September 10, 2002 ¾ Just in time for the cold and flu season, founders of Woodinville, Washington-based Inhalation, Inc., have been granted patent No. 6, 447,816 today by the U. S. Patent and Trademark Office that is entitled “Methods and Apparatus to Prevent Colds, Flus, and Infections of the Human Respiratory System.”

Co-invented by W. Banning Vail, Ph. D., an MIT-educated physicist and holder of over 50 patents in a variety of industries, and his wife, Marilyn L. Vail, the invention combines the age-old and well-documented antibacterial, antiviral, and antifungal benefits of eucalyptus and/or tea tree oil with a convenient, portable personal inhaler that effectively transports the vapors to the sinuses and into the lungs. The patent claims that periodic inhalation of the vapors from these essential oils can provide a protective barrier against inhaled pathogens, preventing the initial infection of the common cold and flu, and therefore also protecting against the escalation of these infections into pneumonia and other respiratory problems. Independent references concerning the effectiveness of eucalyptus oil are quoted at www. NoColds-NoFlus. com.

“My wife and I invented these inhalers after I contracted a terrible lung infection following a plane trip to Houston over 4 years ago,” said Dr. Vail, vice president of Inhalation, Inc. “The infection destroyed one-third of my lung capacity leaving me gasping for breath and believing I was near death. My pulmonary physician diagnosed emphysema and warned that if I contracted another infection, I would likely be tethered to oxygen tanks for the rest of my life. Already suffering from asthma and prone to pneumonia, I almost always got sick when I traveled on planes and otherwise went into public places. My wife learned about the benefits of eucalyptus and tea tree oil during research on an unrelated health issue and she found that the Australian Aborigines have probably been using these oils for millennia. We developed the personal inhaler to provide an efficient and portable means of inhaling the vapors. Since I began inhaling the vapors from our invention over 3 years ago, I have had no lung infections or other respiratory infections. Other individuals have had similar results. These inventions have also dramatically cut my need for standard asthma medicines, including bronchial dilators and inhaled steroids.” 

According to a study published in a July issue of The Journal of the American Medical Association, at least 19% of all airline passengers contacted one week after their trip reported respiratory infections. (JAMA, July 24/31, 2002 - Vol. 288, No. 4, pp. 483-486). This 19% illness rate clearly demonstrates the probability of catching respiratory diseases on aircraft.

In addition to its anti-pathogenic properties, many published references claim that eucalyptus oil thins mucous in the lungs and is a good expectorant after a cold or flu is contracted. The No Colds, No Flus™ Eucalyptus Inhaler contains 100% eucalyptus oil. Many users of the No Sinus Pain™ Inhaler, having both eucalyptus oil and tea tree oil, claim that inhaling these vapors opens up their clogged sinuses within 30 seconds to 2 minutes after use. Until now, inhaling these oils has been extremely difficult to do efficiently. Covering one’s head with a towel and leaning over a steaming bowl of hot water and eucalyptus oil was effective as a home remedy but was neither practical outside the home nor portable. Such boiling techniques are clearly not suitable in crowded airplanes, schools, hospitals, movie theaters and office buildings.

Michael Schiesser, M. D., who practices medicine in Bellevue, WA at the Moss Bay Center for Integrative Medicine, advocates an approach of blending conventional medicine with naturopathic remedies. Such an approach is emphasized in the book edited by Dr. Schiesser entitled “Blended Medicine, The Best Choices in Healing” (Rodale Press, 2000).

“One patient with asthma, and another with bronchitis stated that the No Colds, No Flus™ Inhaler helped to loosen mucous in their chests, and each returned requesting another inhaler,” said Dr. Schiesser. “I have given the No Sinus Pain™ Inhaler to several patients recently with sinus problems, and I have had at least five reports that the inhaler helped to soothe their sinuses and relieve their symptoms.” Dr. Schiesser further states “several people to whom I have provided the inhalers have also claimed that they use them often just because the various oils smell nice.”

The No Colds, No FlusÔ Eucalyptus Lung Inhaler and No Sinus PainÔ Inhaler are available for purchase at www. NoColds-NoFlus. com, along with the No Asthma Attack™ Inhaler, the No Head Ache™ Inhaler, and the No Stress, No Nerves™ Inhaler. The essential oils are 100% natural and are guaranteed to be free of pesticides. The company offers an unconditional money back guarantee on all of its products. 

“Many of our customers now claim that they have a defense against airborne pathogens in airplanes and other public places, when someone coughs or sneezes near them,” said Marilyn Vail, president of Inhalation, Inc. “These inhalers have saved my husband’s life and we hope that others will similarly benefit.”

Other U. S. Patent applications filed by the Vails are entitled “Methods and Apparatus to Prevent Colds, Flus, Tuberculosis and Opportunistic Infections of the Human Respiratory System of Individuals Having Cystic Fibrosis” and “Methods and Apparatus to Prevent, Treat, and Cure Infections of the Human Respiratory System Including the Sinus Cavities, the Nasal Cavities, and the Throat.” The approaches in these patent applications also claim the inhalation of vapors from various essential oils or combination of oils.

Seattle-based Eulara Corporation, a plant essential oils company that focuses primarily on skin care products, including antibacterial, antifungal and antiviral applications, recently conducted a series of in vitro anti-microbial tests, which confirm the VailsÂ’ claims in the patent applications, as well as those cited in scientific literature.

“Our company has a substantial collection of human pathogenic bacteria which we use in our testing programs,” said Eulara chairman Dr. Richard Honour. “We challenged the eucalyptus and tea tree oils used in Inhalation, Inc.’s products against a broad collection of human clinical isolates of Staphylococcus, Pseudomonas, Mycobacterium, Salmonella, E. coli and other bacteria. Our test results showed significant, direct anti-microbial activity against these bacteria.” Dr. Honour holds a Ph. D. in Microbiology and Plant Pathology, and can be reached at www. Eulara. com.

Eulara’s test results support the contention, published in various reference materials available through the company, that the oils used in Inhalation’s No Sinus PainÔ inhaler have activity against certain strains of Pseudomonas aeruginosa, which may cause fatal infections of the respiratory system of children suffering from cystic fibrosis. In addition, the patent applications claim that the same combination of oils could also be effective against a wide variety of mycobacteria, including Mycobacterium tuberculosis, which causes TB.

“We are very encouraged by Eulara’s test results,” said Dr. Vail, “but before any of our inhalers are used for these particular purposes, they need FDA approval. We respect the FDA approval process, but due to our currently limited financial resources, we need significant help in this area to test, according to FDA guidelines, whether these inhalers can be used to prevent, treat or cure these infections. We are prepared to provide a large number of inhalers at no cost to interested physicians who see the benefit of further investigating their use in these areas. Until double-blind FDA-sanctioned studies are completed, we will continue to keep track of anecdotal stories from users of the inhalers, and provide quotes from relevant published references. In the meantime, we wish to properly emphasize that the FDA has not evaluated or approved any of the inhalers to diagnose, treat, cure or prevent any disease,” says Dr. Vail.

Inhalation, Inc. is currently in negotiations to license its intellectual property to a limited liability corporation, which will repackage and sell the products in the retail channel. Interested parties are encouraged to contact the company for more information about the opportunity.

About Inhalation, Inc.

Inhalation, Inc., based in Woodinville, WA, was founded in 2000 to provide natural remedies based upon the inhalation of vapors from essential oils. More information on the company and its products is available at www. NoColds-NoFlus. com, at www. InhalationProducts. com, by calling (425) 398-2557, or by contacting Dr. Vail at wbv@NoColds-NoFlus. com.